Back to
SUSQUEHANNA INTERNATIONAL GROUP, LLP
CNTB4 quarters
Position history for
SUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in CONNECT BIOPHARMA HLDGS LTD
Yes. Susquehanna International Group holds 102,148 shares of CNTB (Connect Biopharma), worth $243,112, as of its Q2 2026 13F filing. It reduced the position by 176,660 shares (-63.4%) from Q1 2026. Susquehanna International Group has held CNTB since Q3 2025, across 4 quarterly 13F filings.
Current Value
$243,112
Current Shares
102,148
Total Value Change
+$222,765
Total Shares Change
+88,400
Quarter-by-Quarter History
Other major holders of CNTB: BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP